Despite being unable to declare statistical success, the company claimed its therapy showed enough promise to support moving ...

Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a phase 3 trial for severe alopecia ...

Nektar Therapeutics (NASDAQ:NKTR) reported results from its Phase 2b REZOLVE-AA study evaluating rezpegaldesleukin in patients with severe to very severe alopecia areata, with the trial narrowly ...

Here are the top 5 most-viewed alopecia content in 2025.

For the second time in the last three weeks, AbbVie has revealed successful results from a phase 3 study of Rinvoq as a treatment for the hair-loss disease alopecia areata (AA). The second replicate ...

Kristen Whitney, DO, FAAD, determines systemic treatment options for severe alopecia areata based on the patient’s medical history, past treatments tried, potential adverse events, in addition to the ...

Alopecia areata is a skin disease that makes you lose patches or large sections of hair on your scalp and body. It's not life-threatening, but it can be life-altering. Hair is a part of your identity.

If you have alopecia areata, you are probably no stranger to a roller coaster of emotions. It’s true that this condition isn’t life-threatening and doesn't cause physical pain. But it can impact how ...

Dermatologists, who recently celebrated the US Food and Drug Administration's (FDA's) approval of the world's first oral systemic treatment for adults with severe alopecia areata (AA), are now looking ...

Rodney Sinclair is an investigator in a clinical trial which is testing treatments for alopecia areata mentioned in the article. He is also head of Sinclair Dermatology, one of the Australian trial ...